These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8815002)

  • 1. Interactions between CD44 and hyaluronic acid: their role in tumor growth and metastasis.
    Sy MS; Liu D; Schiavone R; Ma J; Mori H; Guo Y
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():129-53. PubMed ID: 8815002
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan.
    Bartolazzi A; Nocks A; Aruffo A; Spring F; Stamenkovic I
    J Cell Biol; 1996 Mar; 132(6):1199-208. PubMed ID: 8601595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
    Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
    Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 and the adhesion of neoplastic cells.
    Rudzki Z; Jothy S
    Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the CD44/ezrin complex in cancer metastasis.
    Martin TA; Harrison G; Mansel RE; Jiang WG
    Crit Rev Oncol Hematol; 2003 May; 46(2):165-86. PubMed ID: 12711360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-CD44 interactions promote BMP4/7-dependent Id1/3 expression in melanoma cells.
    Wu RL; Sedlmeier G; Kyjacova L; Schmaus A; Philipp J; Thiele W; Garvalov BK; Sleeman JP
    Sci Rep; 2018 Oct; 8(1):14913. PubMed ID: 30297743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
    Harada N; Mizoi T; Kinouchi M; Hoshi K; Ishii S; Shiiba K; Sasaki I; Matsuno S
    Int J Cancer; 2001 Jan; 91(1):67-75. PubMed ID: 11149422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
    Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
    Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 and hyaluronan binding by human myeloid cells.
    Smadja-Joffe F; Legras S; Girard N; Li Y; Delpech B; Bloget F; Morimoto K; Le Bousse-Kerdiles C; Clay D; Jasmin C; Levesque JP
    Leuk Lymphoma; 1996 May; 21(5-6):407-20, color plates following 528. PubMed ID: 9172805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint features of metastasis formation and lymphocyte maturation and activation.
    Zöller M
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():215-47. PubMed ID: 8814989
    [No Abstract]   [Full Text] [Related]  

  • 11. To metastasize or not? Selection of CD44 splice sites.
    Cooper DL; Dougherty GJ
    Nat Med; 1995 Jul; 1(7):635-7. PubMed ID: 7585142
    [No Abstract]   [Full Text] [Related]  

  • 12. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration.
    Murai T; Maruyama Y; Mio K; Nishiyama H; Suga M; Sato C
    J Biol Chem; 2011 Jan; 286(3):1999-2007. PubMed ID: 21087933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the hyaluronan receptor, CD44, by its transmembrane and cytoplasmic domains.
    Sheikh H; Uff CR; Peck D; Isacke CM
    Biochem Soc Trans; 1995 Nov; 23(4):831-5. PubMed ID: 8654848
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44.
    Zhang M; Singh RK; Wang MH; Wells A; Siegal GP
    Clin Exp Metastasis; 1996 May; 14(3):268-76. PubMed ID: 8674281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 and its partners in metastasis.
    Jothy S
    Clin Exp Metastasis; 2003; 20(3):195-201. PubMed ID: 12741678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
    Sleeman J; Rudy W; Hofmann M; Moll J; Herrlich P; Ponta H
    J Cell Biol; 1996 Nov; 135(4):1139-50. PubMed ID: 8922392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
    Matou-Nasri S; Gaffney J; Kumar S; Slevin M
    Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44.
    Somasunderam A; Thiviyanathan V; Tanaka T; Li X; Neerathilingam M; Lokesh GL; Mann A; Peng Y; Ferrari M; Klostergaard J; Gorenstein DG
    Biochemistry; 2010 Oct; 49(42):9106-12. PubMed ID: 20843027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of CD44RC, a novel alternatively spliced soluble CD44 isoform that can potentiate the hyaluronan binding activity of cell surface CD44.
    Chiu RK; Carpenito C; Dougherty ST; Hayes GM; Dougherty GJ
    Neoplasia; 1999 Nov; 1(5):446-52. PubMed ID: 10933060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan.
    Catterall JB; Jones LM; Turner GA
    Clin Exp Metastasis; 1999; 17(7):583-91. PubMed ID: 10845557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.